Rebhan Dissertation ohne Lebenslauf - OPUS - Universität Würzburg

older subjects with exercise-induced myocardial ischemia. Circulation 98:
1504-9, 1998.
69. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK,
Jr. Carotid-artery intima and media thickness as a risk factor for
myocardial infarction and stroke in older adults. Cardiovascular Health
Study Collaborative Research Group. N Engl J Med 340: 14-22, 1999.
70. Panza JA. High-normal blood pressure--more "high" than "normal". N
Engl J Med 345: 1337-40, 2001.
71. Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M, Heiss
G. Arterial stiffness and the development of hypertension. The ARIC
study. Hypertension 34: 201-6, 1999.
72. Goto K, Sakurai T, Kasuya Y. Molecular pharmacology of endothelin in
the cardiovascular system. Nippon Yakurigaku Zasshi 100: 205-18, 1992.
73. Haynes WG, Webb DJ. Endothelin: a long-acting local constrictor
hormone. Br J Hosp Med 47: 340-9, 1992.
74. Ahlborg G, Weitzberg E, Lundberg JM. Circulating endothelin-1 reduces
splanchnic and renal blood flow and splanchnic glucose production in
humans. J Appl Physiol 79: 141-5, 1995.
75. Lam HC, Lee JK, Chiang HT, Koh SJ, Han TM, Lu CC, Yang CY, Hao LJ.
Does endothelin play a role in the pathogenesis of early diabetic
nephropathy? J Cardiovasc Pharmacol 26 Suppl 3: S479-S481, 1995.
76. Lüscher TF. Endothelin. Key to coronary vasospasm? Circulation 83:
701-3, 1991.
77. Shichiri M, Iwamoto H, Marumo F. Diabetic hypouricemia as an indicator
of clinical nephropathy. Am J Nephrol 10: 115-22, 1990.